MedTrace Logo

Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)

NCT01067430 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-06-23

No results posted yet for this study

Summary

The purpose of this study is to explore the effect of Etoricoxib compared to Diclofenac on physical activity in RA subjects with early morning pain and stiffness.

Conditions

Interventions

DRUG

Etoricoxib

Film coated tablet, 90 mg taken once a day for 14 days

DRUG

Diclofenac

Enteric coated tablet 50 mg given three times a day for 14 days

Sponsors & Collaborators

  • Northumbria Healthcare NHS Foundation Trust

    lead OTHER

Principal Investigators

  • David J Walker, MD · Northumbria Healthcare NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-10-31
Completion
2011-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067430 on ClinicalTrials.gov